The Chicago Entrepreneur

Johnson & Johnson wins FDA approval for first chemotherapy-free lung-cancer treatment

Lung cancer is the leading cause of cancer deaths worldwide.

Previous post Amer Sports’ stock rises on stronger-than-expected sales as loss narrows
Next post Medtronic’s stock extends gains after earnings beat and raised outlook